A pooled CRISPR screen reveals genes critical for erythroblast enucleation

This study utilizes a pooled CRISPR-Cas9 screen in enucleated human red blood cells to identify CLIC3 and VAMP8 as critical regulators of terminal erythroid differentiation, which function through distinct mechanisms involving cell cycle coordination and actin-mediated nuclear polarization, respectively.

The Gist

Imagine your body is a bustling city, and its most important delivery trucks are red blood cells. These trucks are special because they don't have a driver's cab (a nucleus); they are streamlined, flexible, and packed entirely with cargo (oxygen). To become these perfect delivery trucks, a precursor cell has to go through a dramatic transformation where it literally kicks its own "driver's cab" (the nucleus) out of the building. This process is called enucleation.

For a long time, scientists were stumped. They knew the process happened, but they didn't know the "blueprints" or the "construction crew" that made it work. Why? Because once the cell kicks out its nucleus, it loses its DNA. Without DNA, you can't easily run genetic experiments to see which parts are essential. It's like trying to fix a car engine after you've thrown the instruction manual out the window.

This paper describes a clever new way to solve that puzzle and the two new "construction workers" they found.

The Detective Work: A "Lost and Found" Strategy

The researchers needed a way to test genes in cells that no longer had a nucleus. They came up with a brilliant trick:

1. The Messenger Bag: Usually, genetic instructions (like CRISPR guides) stay in the nucleus. But the team used a special "backpack" (a modified virus called CROPseq) that puts the instructions into a messenger bag (mRNA) that travels out to the cell's main floor (cytoplasm).
2. The Tag: Even after the cell kicks out its nucleus, this messenger bag stays behind. It's like leaving a sticky note on the dashboard of a car after the driver has left.
3. The Screen: They took thousands of stem cells, gave each one a random "instruction manual" to break a specific gene, and let them grow. Then, they looked at the cells that successfully kicked out their nuclei. If a specific "instruction manual" was missing from the successful cells, it meant that breaking that gene stopped the cell from finishing its job.

The Two New Heroes: CLIC3 and VAMP8

Using this method, they found two genes that are absolutely critical for the process. Think of them as two different foremen on the construction site, each with a very different job.

1. CLIC3: The Traffic Cop

The Job: Keeping the schedule.
What happens when it's missing:
Imagine a construction crew that is supposed to build a house in 10 days. If you remove CLIC3, the crew gets confused. They start panicking, stop working, and get stuck in a holding pattern.

• The Science: The cell stops dividing properly. It activates a "stop" signal (p53 and p21 proteins) that makes the cell cycle drag on. The cell tries to grow but gets stuck in the middle, unable to finish the job of kicking out the nucleus.
• The Analogy: CLIC3 is the Traffic Cop ensuring the construction crew moves forward on time. Without the cop, traffic jams (cell cycle delays) occur, and the project never finishes.

2. VAMP8: The Delivery Driver

The Job: Organizing the moving trucks.
What happens when it's missing:
This one is trickier. If you remove VAMP8, the construction crew actually works too fast at first! They rush through the early stages. But then, when it's time to kick out the nucleus, the machinery falls apart.

• The Science: The cell rushes to maturity but fails to organize its internal "scaffolding" (actin filaments). To kick out the nucleus, the cell needs to build a tight ring of muscle (actin) around the nucleus to squeeze it out. Without VAMP8, this ring is messy and disorganized. The nucleus gets stuck, and the cell can't let go.
• The Analogy: VAMP8 is the Delivery Driver who organizes the moving trucks. Without the driver, the crew rushes to pack up, but the trucks are loaded haphazardly. When they try to move the heavy furniture (the nucleus), the ropes (actin) are tangled, and the furniture gets stuck in the doorway.

Why This Matters

This paper is a big deal for two reasons:

1. New Tools: They invented a new way to study cells that have no DNA. This is like finding a way to read the blueprints of a building even after the architect has left the site. This could help scientists study other diseases where cells lose their nuclei, like platelet disorders or malaria infections.
2. New Insights: They found that making a red blood cell isn't just about one thing; it requires a perfect balance of timing (CLIC3) and organization (VAMP8). If either of these goes wrong, the body can't make healthy blood, potentially leading to anemia.

In short, the researchers built a new detective kit, solved a 40-year-old mystery about how blood cells are made, and discovered that you need both a strict timekeeper and an organized mover to get the job done.

Technical Summary

1. The Problem

Terminal erythroid differentiation culminates in enucleation, the process where late-stage erythroblasts expel their nucleus to become functional, flexible red blood cells (RBCs). While essential for oxygen transport, the molecular mechanisms driving enucleation remain poorly understood.

• Technical Barrier: Traditional forward-genetic screening (using CRISPR or RNAi) relies on next-generation sequencing (NGS) of nucleic acids to track genetic perturbations. However, mature, enucleated RBCs lack a nucleus and genomic DNA, making it impossible to sequence sgRNAs or shRNAs in the final cell population.
• Limitations of Existing Models: Cell lines exhibit low enucleation rates and fail to recapitulate key biological features of terminal erythropoiesis. Primary erythroblasts derived from hematopoietic stem/progenitor cells (HSPCs) enucleate efficiently but have historically been inaccessible to pooled genetic screens due to the lack of nucleic acid in the final product.

2. Methodology

The authors developed a novel workflow to perform pooled CRISPR-Cas9 screening in enucleated human RBCs derived from primary CD34+ HSPCs.

• Ex-vivo Erythropoiesis: Primary human CD34+ HSPCs were cultured to undergo terminal differentiation, achieving >90% enucleation after ~18–20 days.
• CROPseq Vector Adaptation: To overcome the loss of nuclear DNA, the authors utilized a modified CROPseq vector. Instead of the standard U6 promoter (which keeps sgRNA in the nucleus), the sgRNA cassette was embedded into the 3' LTR of the lentiviral vector. This ensures the sgRNA is transcribed as part of a polyadenylated mRNA transcript, allowing it to be exported to the cytoplasm and retained in the cell after enucleation.
• Optimized Editing (SLICE + LRG2.1):
  • Delivery: They employed the SLICE strategy (sgRNA Lentiviral Infection with Cas9 protein Electroporation). Cells were transduced with the sgRNA library, followed by nucleofection of recombinant Cas9-NLS protein.
  • Scaffold Optimization: The original CROPseq scaffold contained a run of four thymidines (TTTT) that interfered with Cas9 efficiency. The authors replaced the scaffold with LRG2.1, which lacks this sequence, significantly improving knockout efficiency.
• Screening Design:
  • A custom library targeting 681 genes (RBC proteome, excluding essential genes) was used, comprising ~5,000 sgRNAs.
  • Cells were harvested at Day 8 (baseline), Day 17 (unsorted), and Day 17 (FACS-sorted enucleated cells).
  • sgRNA abundance was quantified via RNA-seq from total mRNA, comparing the enucleated population against the unsorted population to identify hits.

3. Key Contributions

• Methodological Breakthrough: Established the first successful pooled CRISPR screen in enucleated primary human cells, proving that sgRNAs embedded in mRNA can be tracked post-enucleation.
• Discovery of Novel Regulators: Identified CLIC3 and VAMP8 as critical, previously uncharacterized factors in terminal erythroid differentiation and enucleation.
• Mechanistic Insights: Elucidated two distinct mechanisms by which these genes regulate enucleation: one via cell cycle coordination and the other via cytoskeletal organization.

4. Key Results

A. Validation of the Screening Platform

• The modified CROPseq-LRG2.1 system successfully retained sgRNA sequences in enucleated cells, detectable by RT-PCR and RNA-seq.
• The pilot screen confirmed library stability throughout differentiation, validating the approach for large-scale screening.

B. CLIC3 (Chloride Intracellular Channel 3)

• Phenotype: Knockdown of CLIC3 resulted in a delay in erythroblast differentiation and a severe impairment in enucleation (~30% enucleation vs. ~80% in controls).
• Mechanism:
  • RNA-seq revealed upregulation of the p53/p21 pathway.
  • CLIC3-KD cells showed increased p53 protein and significantly elevated p21 (CDKN1A) mRNA and protein levels.
  • Cell cycle analysis (EdU incorporation) showed a shift from S-phase to G1 arrest.
  • Conclusion: CLIC3 is required to coordinate cell cycle progression and prevent premature p53/p21 activation, which is necessary for cells to reach the stage of enucleation.

C. VAMP8 (Vesicle Associated Membrane Protein 8)

• Phenotype: VAMP8-KD cells initially appeared to differentiate faster (accelerated maturation) but subsequently failed to enucleate, accumulating as late-stage nucleated orthochromatic erythroblasts.
• Mechanism:
  • Mitochondrial Clearance: Unlike the VDAC1-KD phenotype, VAMP8-KD cells cleared mitochondria normally, ruling out a defect in mitophagy.
  • Transcriptional Analysis: RNA-seq showed enrichment in pathways related to actin binding and vesicle trafficking.
  • Cytoskeletal Defects: Immunofluorescence revealed that VAMP8-KD cells had impaired nuclear polarization and disorganized actin. While wild-type cells formed organized F-actin foci (resembling a contractile actin ring) at the extrusion site, VAMP8-KD cells exhibited misshapen nuclei and aggregated, disorganized actin.
  • Conclusion: VAMP8 is essential for orchestrating the actin rearrangements and vesicular trafficking required for nuclear polarization and the physical expulsion of the nucleus.

5. Significance

• Overcoming a Biological Bottleneck: This study provides a robust framework for functional genomics in anucleated cells, opening the door to studying other processes involving enucleated cells (e.g., reticulocyte maturation, platelet development, and host-pathogen interactions in malaria).
• New Molecular Targets: The identification of CLIC3 and VAMP8 expands the known molecular toolkit for erythropoiesis.
  • CLIC3 links chloride channel function/oxidoreductase activity to cell cycle control via the p53/p21 axis.
  • VAMP8 reveals a non-canonical role for a SNARE protein in cytoskeletal dynamics and nuclear polarization, distinct from its known role in autophagy.
• Clinical Relevance: Understanding these mechanisms offers potential insights into congenital anemias and ineffective erythropoiesis where cell cycle dysregulation or enucleation failure occurs. The study suggests that future therapies could target these pathways to improve RBC production.